{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:06:09Z","timestamp":1760954769181},"reference-count":15,"publisher":"Informa Healthcare","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1517\/13543784.13.4.431","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T21:27:20Z","timestamp":1115242040000},"page":"431-434","source":"Crossref","is-referenced-by-count":1,"title":["Do vasopressin receptor type 2 antagonists have therapeutic potential in polycystic kidney diseases?"],"prefix":"10.1517","volume":"13","author":[{"given":"Sheila A","family":"Doggrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,3,2]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1038\/nm935"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra022161"},{"key":"CIT0003","first-page":"F370\u2013F382","volume":"279","author":"PROMENEUR D","year":"2000","journal-title":"Am. Physiol Renal Physic]"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00991.x"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","volume":"11","author":"HANAOKA K","year":"2000","journal-title":"J. Am. Soc. Nephrol"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1992.tb09058.x"},{"key":"CIT0007","first-page":"546","volume":"272","author":"OHNISHI A","year":"1995","journal-title":"Pharmacol Exp. Ther."},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1038\/ng833"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1038\/ng1216"},{"key":"CIT0010","first-page":"194","volume":"289","author":"BOSCH-MARCE M","year":"1999","journal-title":"Pharmacol Exp. Ther."},{"key":"CIT0011","first-page":"83","volume":"295","author":"JIMENEZ W","year":"2000","journal-title":"Pharmacol Exp. Ther."},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36375"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50021"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50143"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000070422.41439.04"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.13.4.431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T15:30:27Z","timestamp":1625931027000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.13.4.431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,3,2]]},"published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1517\/13543784.13.4.431"],"URL":"https:\/\/doi.org\/10.1517\/13543784.13.4.431","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}